162 related articles for article (PubMed ID: 9804056)
1. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models.
Matsushita N; Hizue M; Aritake K; Hayashi K; Takada A; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):1-10. PubMed ID: 9804056
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Ueno M; Inagaki N; Nagai H; Koda A
Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
[TBL] [Abstract][Full Text] [Related]
5. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
7. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Misawa M; Kanai Y
Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
[TBL] [Abstract][Full Text] [Related]
8. [Antiallergic effects of a novel compound, SWR-00151].
Tanaka Y; Masai E; Yashima T; Furukawa M
Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic/antiasthmatic activity of oligopeptide related to IgE.
Singh R; Nath A; Gupta PP; Shulka M; Khare SK; Kundu B
Pharmacol Res; 1998 May; 37(5):353-6. PubMed ID: 9642030
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
Fügner A; Meissner C
Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
[TBL] [Abstract][Full Text] [Related]
12. Anti‑allergic action of bacillus Calmette‑Guerin extract in experimental mast cell‑mediated anaphylactic models.
Sun M; Wang Y; Zhao H; Yao W; Yu X
Mol Med Rep; 2017 Nov; 16(5):6248-6254. PubMed ID: 28901381
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-scratch properties of oxatomide and epinastine in mice.
Inagaki N; Nagao M; Nakamura N; Kawasaki H; Igeta K; Musoh K; Nagai H
Eur J Pharmacol; 2000 Jul; 400(1):73-9. PubMed ID: 10913587
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies on KW-4679, an antiallergic drug. (1): Inhibitory effect on passive cutaneous anaphylaxis (PCA) and experimental asthma in rats and guinea pigs].
Ishii H; Sasaki Y; Ikemura T; Kitamura S; Ohmori K
Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):289-98. PubMed ID: 8537076
[TBL] [Abstract][Full Text] [Related]
15. VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.
Takizawa T; Matsumoto J; Tohma T; Kanke T; Wada Y; Nagao M; Inagaki N; Nagai H; Zhang MQ; Timmerman H
Jpn J Pharmacol; 2001 May; 86(1):55-64. PubMed ID: 11430473
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled KAA-276, a selective histamine H1 receptor antagonist, on antigen- and histamine-induced bronchoconstriction in animals.
Kobayashi T; Takehana Y; Shinagawa K; Tsuyuki S; Tokutake Y; Sato M; Momose D
Arzneimittelforschung; 1998 Aug; 48(8):826-31. PubMed ID: 9748711
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs.
Tohda Y; Nakajima S; Shizawa T; Maeda K; Ohmori S; Satoh H; Ishii T; Kamitani T
Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875
[TBL] [Abstract][Full Text] [Related]
18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
19. Preclinical comparison of ebastine and other second generation H1-antihistamines.
Yakuo I; Yabuuchi M; Ito T
Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
[TBL] [Abstract][Full Text] [Related]
20. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]